Abing, Hazel Faith .
HRN: 24-31-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
01/02/2024
01/09/2024
ORAL
1ml
Qid
Mouth Sores
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes